Tag Archives: Risk Reduction

International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)

Posted on August 24, 2020 by Dementia and Elderly Care News

Summary A selection of recent articles presents a surprising consensus on the issues in question, across disparate international regions. First, an article written from the context of India: Full Text Link Reference Rina, K. Maiti, T. Panigrahi, M. Patro, B. … Continue reading →

Posted in Community Care, Depression, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Management of Condition, Mental Health, Person-Centred Care, Quick Insights, Universal Interest | Tagged Abuse Intervention / Prevention Model (AIM), Abuse of Vulnerable Adults, Ageism, All India Institute of Medical Sciences (Bhubaneswar; India), American Journal of Geriatric Psychiatry, Black Country Healthcare NHS Foundation Trust (Wolverhampton; UK), Casual Ageism, Center for Health Equity Research and Promotion: VA Pittsburgh Healthcare System, Department of Community Medicine and Family Medicine, Department of Department of Community Medicine and Family Medicine: All India Institute of Medical Sciences (AIIMS), Department of Family Medicine: University of Southern California, Department of Medicine: University of Pittsburgh School of Medicine, Department of Psychiatry: All India Institute of Medical Sciences (AIIMS), Detecting Elder Abuse, Elder Abuse, Elder Abuse in Coronavirus Disease 2019 (COVID-19) Era, Emotional Abuse, Estimated Global Prevalence of Elder Abuse, Financial Abuse, IMS and SUM Hospital (Bhubaneswar; India), India, Institutional Abuse, International Comparisons, Journal of the American Geriatrics Society, Mental Illness Research Education and Clinical Center: VA Pittsburgh Healthcare System, Negative Impact of Ageist Attitudes, Patterns of Abuse and Harm, Psychological Abuse, Risk Reduction, School of Gerontology: University of Southern California, United States, University of Pittsburgh School of Medicine, University of Southern California, USA, VA Pittsburgh Healthcare System, Wolverhampton | Leave a comment

Summary of NICE’s Impact on Dementia Health and Care (NICE)

Posted on February 9, 2020 by Dementia and Elderly Care News

Summary A National Institute for Health and Care Excellence (NICE) marketing report gives an overview of progress in implementing NICE guidance across health and care. The main section headings comprise: Prevent or delay onset of dementia. Referral, diagnosis and care … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NICE Guidelines, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Activities to Promote Wellbeing, Adult Social Care, Adult Social Care Services, Advance Care Planning (ACP), Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Alternatives to Antipsychotics, Antipsychotic Drugs, Antipsychotics in People With Dementia, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Assessment of Care Needs, Avoidable Emergency Admissions, Behavioural and Psychological Symptoms of Dementia (BPSD), Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Care and Support, Care and Support Planning, Care of People with Dementia: Quality Standard, Care Planning, Care Planning (Community), Care Planning in Dementia, Caregiver Support, Carer Support, Carer Support Services, Carer's Needs, Carer’s Needs Assessment, Choice and Control, Choice and Control Over Decisions, Choice in Health and Social Care, Choirs (Community Singing), Cognitive Decline and Dementia: Risk Reduction, Collaboration for Coordinated Care, Commissioning Carer Support Services, Community Singing, Comprehensive Assessments for Older People in Hospital, Comprehensive Model of Personal Care, Control and Independence, Coordinated Care, Coordinating Care, Dementia - Assessment Management and Support for People Living With Dementia and Their Carers: NICE Guideline NG97, Dementia - NICE Care Pathway, Dementia Assessment Referral to GP (DeAR-GP), Dementia Care in Acute General Hospitals, Dementia Care in Acute Settings, Dementia Care in Hospitals, Dementia Case Finding, Dementia Disability and Frailty in Later Life: Mid-Life Approaches to Delay or Prevent Onset, Dementia Disability and Frailty in Later Life: Mid-Life Approaches to Delay or Prevent Onset - NICE Care Pathway, Dementia Disability and Frailty in Later Life; Midlife Approaches to Delay or Prevent Onset: NICE Guideline (NG16), Dementia Friendly Hospitals Charter, Dementia Post-Diagnostic Care and Support, Dementia Quality Standard (QS184), Dementia Quality Standards, Dementia Risk Factors, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Discharge From Hospital, Dr Hilda Hayo: Chief Admiral Nurse, Dr Hilda Hayo: Chief Executive of Dementia UK, Emergency Admissions, Healthwatch, Healthy Lifestyles, Home Care, Informed Choices, Later Life, Lifestyle Risk Factors, Managing Distress, Managing Psychological and Behavioural Distress in People with Dementia, Meaningful Activity, Mental Health Promotion, Mid-Life Approaches to Delay or Prevent Onset of Dementia Disability and Frailty in Later Life, Modifiable Risk Factors, Named Care Coordinators, National Audit of Dementia Care in General Hospitals 2016-2017 - Third Round of Audit Report: Royal College of Psychiatrists (2017), National Guidance and Quality Standards, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE)’s Quality Standard on Dementia (2019), Needs of Carers, Neurological Disorders, NHS Comprehensive Model of Personal Care, NICE Guideline NG97: Dementia - Assessment Management and Support for People Living With Dementia and Their Carers, NICE Quality Standard 184 (QS184), NICEimpact Dementia, Patient Preferences, Person-Centred Coordinated Care, Personal Preferences, Preventing Avoidable Emergency Admissions, Prevention Agenda, Psychological Symptoms of Dementia (BPSD), Quality of Life of Carers, Quality Standard on Care of People with Dementia, Quality Statements, Reducing Agitation and Distress, Reducing Waste in Dementia Care, Reducing Waste in the NHS, Risk Reduction, Royal College of Psychiatrists: National Audit of Dementia Care in General Hospitals, Social Care, Social Care and Support, Statement of Wishes and Preferences, Structured Assessment (Pre- Non-Pharmacological or Pharmacological Treatment for Distress), Supporting Carers, Supporting Carers of People With Dementia, Supporting People to Live Well With Dementia, Thinking Ahead - Advance Care Planning, Transforming Dementia Care in Hospital, Transition Between Inpatient Hospital Settings and Community or Care Home Settings | Leave a comment

More on the Association Between Poor Oral Hygiene and Dementia / Alzheimer’s Disease Risk (NHS Choices / Journal of the American Geriatrics Society)

Posted on March 14, 2017 by Dementia and Elderly Care News

Summary Poor dental hygiene and tooth loss appear to be associated with an increased risk of developing dementia, according to research from Japan. Full Text Link Reference ‘Tooth loss link to increased risk of dementia’. London: NHS Choices; Behind the … Continue reading →

Further Press Releases and Documents Relating to the 2016 Alzheimer’s Association International Conference (Alzheimer’s Association International Conference)

Posted on August 1, 2016 by Dementia and Elderly Care News

Summary A list of press-releases is available relating to some of the main presentations at the Alzheimer’s Association International Conference, held in Toronto last week. Full Text Link Reference Alzheimer’s Association International Conference® 2016. List of Press Releases. [Toronto. Online]: … Continue reading →

Posted in Antipsychotics, Charitable Bodies, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Statistics, Universal Interest | Tagged 2016 Alzheimer’s Association International Conference (AAIC®2016), ADAPT-FS Research Group, Alzheimer Disease Anti-inflammatory Prevention Trial (ADAPT), Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT), Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study (ADAPT-FS), Alzheimer's Disease Neuroimaging Initiative, Alzheimer’s Association, Alzheimer’s Association AAIC Press Office, Alzheimer’s Association International Conference® (AAIC®) 2016, Alzheimer’s Disease and Related Dementias (ADRD) Milestones (United States), Alzheimer’s Disease Research in Ibero America, Amyotrophic Lateral Sclerosis (ALS), Australian Reduction in Use of Antipsychotics in Dementia Care, Avoidable Hospital Admissions, Avoidable Hospitalizations of People With Alzheimer’s Disease: Cost to Medicare (USA), Behavioural and Psychological Symptoms of Dementia (BPSD), Beta-Amyloid PET Imaging, Canadian Research: Advances in Dementia Care, Celecoxib, Celecoxib (Selective COX-2 Inhibitor), Centro de Investigatición y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dementia-Related Misdiagnosis, Dementia-Related Misdiagnosis (Male), Disclosure, Disclosure of Risk Marker Status, Disclosure Protocols for Disclosing APOE Genotype for Risk of Dementia, Epidemiology of Alzheimer's disease in Ibero America, Estudio Nacional de Salud y Envejecimiento en México (ENASEM), Ethical Challenges in Preclinical Alzheimer’s Disease Studies and Trials, Ethical Considerations, Ethical Dilemmas, Ethics, Ethics and Consent, Eye Tests for Detection of Memory Decline and Dementia, Flanders-Belgian Patient Group, Formal Education and Complex Work (Cognitive Reserve), French Three-City Study, Frontotemporal Lobar Degeneration (FTLD), Genome-Wide Association Studies, Genome-Wide Association Studies (GWAS), Genome-Wide Association Study, Genotyping, Ibero America, International Genomics of Alzheimer's Project (IGAP), Latin America, Low Testosterone and Risk of Dementia, Men Receiving Dementia-Related Misdiagnoses More Than Women, Mild Behavioral Impairment (MBI), Milestones for Care and Support in U.S. National Plan to Address Alzheimer's Disease, Naproxen, Naproxen (Nonselective Cyclooxygenase [COX] Inhibitor), Neurodegeneration, Neurodegenerative Disease Research, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), NSAIDS: Non-Steroidal Anti-Inflammatory Drugs, p.R47H rs75932628 in TREM2 (Encoding the Triggering Receptor Expressed on Myeloid Cells 2 Gene on Chromosome 6p21), Preclinical Alzheimer's Disease, Preclinical Biomarkers and Dementia, Preclinical Indicators and Dementia, Preclinical Indicators in Alzheimer's Disease, Reduction of Systematic Sedation in Dementia Care, Research and Development, Research and Innovation, Research Commitment, Risk Prevention, Risk Reduction, Risk Reduction (Formerly Termed Prevention by WDC), SABE (Salud Bienestar y Envejecimiento), Single SNP Associations in Flanders-Belgian AD Cohort, Smell and Eye Tests for Detection of Memory Decline and Dementia, Smell Tests For Detection of Memory Decline and Dementia, SNP rs75932628, Stopping Systemic Sedation, Systemic Sedation, Tau Pathogenesis, Tau Therapeutic Strategies, Testosterone Depletion and Increased Risk of Dementia, Three-City Study, Treating People with Alzheimer’s Disease Increases Survival and Reduces Cost of Care (vs. Non-Treatment), TREM2 R47H as a Risk Factor, USA National Plan to Address Alzheimer's Disease, Vascular Care Intervention To Prevent Dementia | Leave a comment

Significant Changes at the World Dementia Council? (WDC)

Posted on February 28, 2016 by Dementia and Elderly Care News

Summary There has been reform within the World Dementia Council (WDC). The changes are intended to make this body “more representative” in global terms (if such were possible) and fully independent. The Council now includes a wider range of international … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, Diagnosis, For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest, World Health Organization (WHO) | Tagged Abuse of Vulnerable Adults, Academia-Industry Partnerships, Academic Research, Alternatives to Antipsychotic Drugs, Alzheimer's Association, Alzheimer’s Disease: Risk Factors, Alzheimer’s Research UK (ARUK), Argentina, ARUK: Alzheimer’s Research UK, Assistive Technology, Associate Members (WDC), Awareness, Awareness Raising, Behavioural Risk Factors, Big Data, Big Data Partnership, Big Pharma, Bill and Melinda Gates Foundation, Biopharmaceutical Companies, Biotechnology, Challenge on Dementia (David Cameron), Charitable Funding, Clinical Trial Efficiencies, Collaboration, Collaborative Projects, Cross-Sector Partnerships, Data Sharing, Dementia Challenge, Dementia Consortium, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Friends, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, Department of Health’s Integrated Development Initiative, Digital Technology, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), Emerging Technology, Enabling Technology, Future Long-Term Care Costs, GAAD: Global Action Against Dementia, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Outlook, Global Social Investment for Dementia, Government Research Funding, Hilary Doxford: World Dementia Council Member, Indonesia, Information Technology, Innovative Technology, International Collaborations, International Dementia Research Inventories, International Programmes, Interventions for Social Isolation and Loneliness in Men, Investment in Technology, Join Dementia Research, Leveraging Big Data, Lifestyle Risk Factors, Loneliness and Social Isolation, Modifiable Risk Factors, National Institute of Ageing (NIA), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Research, Nigeria, Open Data and Big Data, Organisation for Economic Co-operation and Development (OECD), Partnership and Collaboration, Partnership Working, Philanthropic Funding, Pipeline Databases, Prevention, Prevention of Dementia, Prime Minister’s Challenge On Dementia 2020, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Raj Long: Vice Chair of World Dementia Council, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Stigma, Regulatory Agencies, Regulatory Experts, Research and Development, Research and Innovation, Research Commitment, Research Funding, Resource and Incentives, Restraint and Restrictions, Restraint in Health and Adult Social Care, Risk Factors, Risk Reduction, Risk Reduction (Formerly Termed Prevention by WDC), Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Social Isolation, Stigma, Taiwan, Treatment and Prevention of Dementia, US National Institute on Aging, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO), Yves Joanette: Chair of World Dementia Council | Leave a comment

National Dementia Policy: Formation of Dementia Advisory Group (Department of Health / Dementia Challenge)

Posted on December 21, 2014 by Dementia and Elderly Care News

Summary The Department of Health intends to publish a renewed “vision” for strategic direction, with plans up to 2020, on the future of dementia policy in England. It should be ready by early 2015. This will continue and extend existing … Continue reading →

Tag Archives: Risk Reduction

More on the Association Between Poor Oral Hygiene and Dementia / Alzheimer’s Disease Risk (NHS Choices / Journal of the American Geriatrics Society)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites